oral mesalamin asacol activ ulcer coliti multicent studi object efficaci safeti ph-sensit polymer-co oral prepar mesalamin patient activ ulcer coliti design multicent double-blind placebo-control random trial set university-bas medic center inflammatori bowel diseas center privat practic site patient total patient activ ulcer coliti intervent ph-sensit polymer-co oral prepar mesalamin acid g/d week measur efficaci score stool frequenc rectal bleed patient function assess sigmoidoscop find physician global assess stringent criteria diseas activ result analysi protocol-compli patient signific improv week patient g/d mesalamin patient placebo week g/d g/d dose superior addit patient placebo group g/d group signific differ g/d mesalamin group placebo group oral mesalamin tablet signific chang hematolog hepat renal laboratori profil conclus colon-target oral mesalamin g/d effect therapi activ ulcer coliti toler viabl therapeut altern 